Mosseri Marlio Charles
SEC insider (Form 3/4/5 filer). CIK 0001806384. 10% Owner at Nuvectis Pharma, Inc. (NVCT). 26 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in LONDON.
Companies Mosseri Marlio Charles has filed insider reports for
- Nuvectis Pharma, Inc. (NVCT): 10% Owner
Mosseri Marlio Charles
CIK: 0001806384
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nuvectis Pharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Jun 30, 2026NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect50K shares at avg. $18.32$916K - Oct 27, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect72.8K shares at avg. $6.28$457K - Oct 24, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect35K shares at avg. $6.15$215K - Oct 23, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect46.9K shares at avg. $6.06$284K - Jun 20, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect5.6K shares at avg. $7.99$45K - Jun 18, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect28K shares at avg. $8.05$226K - Jun 17, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect5.4K shares at avg. $8.11$44K - May 12, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect21.2K shares at avg. $8.11$172K - May 9, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect9.9K shares at avg. $8.95$88K - May 9, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseIndirect9.8K shares at avg. $8.90$87K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | NVCT Nuvectis Pharma, Inc. | Purchase | 50,000 | $18.32 | $916,000 | Indirect |
| Oct 27, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 72,836 | $6.28 | $457,410 | Indirect |
| Oct 24, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 35,034 | $6.15 | $215,459 | Indirect |
| Oct 23, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 46,900 | $6.06 | $284,214 | Indirect |
| Jun 20, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 5,603 | $7.99 | $44,768 | Indirect |
| Jun 18, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 28,043 | $8.05 | $225,746 | Indirect |
| Jun 17, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 5,399 | $8.11 | $43,786 | Indirect |
| May 12, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 21,167 | $8.11 | $171,664 | Indirect |
| May 9, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 9,850 | $8.95 | $88,128 | Indirect |
| May 9, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 9,817 | $8.90 | $87,412 | Indirect |
1-10 of 26 transactions